Abstract
Initial stages of tumour growth are not easily accessible to investigation. Therefore an experimental procedure was developed to mimic tumorigenesis as closely as possible. BALB/c mice received intraperitoneally exponentially increasing numbers of irradiated syngeneic ADJ-PC-5 plasmacytoma cells. The initial injection began with two cells per mouse and according to the generation time of this tumour, subsequent doses were doubled until mice had received up to 10(5) tumour cells. At various stages of treatment, peritoneal exudate cells (PEC) and spleen cells (SC) were tested for either cytotoxicity or specific suppression of induction of a primary in vitro T-cell cytotoxic response (CTL) of BALB/c spleen cells against ADJ-PC-5 plasmacytoma cells. No cytotoxic PEC were found. Instead, PEC from mice in which the final tumour cells number had reached or exceeded 10(3) irradiated ADJ-PC-5 cells, induced complete suppression of this primary in vitro CTL. Specificity was found both in the induction and effector phase of suppression. Specific suppression was mediated by Thy-1.2+ cells and amplified by non-specific suppression through adherent cells. The data arae discussed in context with previous findings on the in vivo immunogenicity and tolerogenicity of the ADJ-PC-5 plasmacytoma. They suggest that induction of T suppressor (Ts) cells might be an early event in tumorigenesis.
Full text
PDF![503](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e1/1555547/2e24245490da/immunology00224-0103.png)
![504](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e1/1555547/0f7c7253d60d/immunology00224-0104.png)
![505](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e1/1555547/6d2870abdd3c/immunology00224-0105.png)
![506](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e1/1555547/803486d22a96/immunology00224-0106.png)
![507](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e1/1555547/6e5125d46961/immunology00224-0107.png)
![508](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e1/1555547/6e31b3247f8e/immunology00224-0108.png)
![509](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e1/1555547/3d2003a089b5/immunology00224-0109.png)
![510](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e1/1555547/acfd51ea158e/immunology00224-0110.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berendt M. J., North R. J. T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor. J Exp Med. 1980 Jan 1;151(1):69–80. doi: 10.1084/jem.151.1.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bonmassar E., Goldin A., Cudkowicz G. Differential reactivity of mice to alloantigens associated with the D and K end of H-2: preliminary studies with bone marrow and lymphoma grafts. Transplantation. 1971 Oct;12(4):314–318. doi: 10.1097/00007890-197110000-00014. [DOI] [PubMed] [Google Scholar]
- Brunner K. T., Mauel J., Cerottini J. C., Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology. 1968 Feb;14(2):181–196. [PMC free article] [PubMed] [Google Scholar]
- Burton R. C., Warner N. L. Tumor immunity to murine plasma cell tumors. III. Detection of common and unique tumor-associated antigens on BALB/c, C3H, and NZB plasmacytomas by in vivo and in vitro induction of tumor-immune responses. J Natl Cancer Inst. 1977 Mar;58(3):701–709. doi: 10.1093/jnci/58.3.701. [DOI] [PubMed] [Google Scholar]
- Cihak J., Ziegler H. W., Kölsch E. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved. Immunology. 1981 May;43(1):133–143. [PMC free article] [PubMed] [Google Scholar]
- Collins J. L., Patek P. Q., Cohn M. Tumorigenicity and lysis by natural killers. J Exp Med. 1981 Jan 1;153(1):89–106. doi: 10.1084/jem.153.1.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dye E. S., North R. J. T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases. J Exp Med. 1981 Oct 1;154(4):1033–1042. doi: 10.1084/jem.154.4.1033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fujimoto S., Greene M. I., Sehon A. H. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts. J Immunol. 1976 Mar;116(3):791–799. [PubMed] [Google Scholar]
- Fujimoto S., Greene M. I., Sehon A. H. Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts. J Immunol. 1976 Mar;116(3):800–806. [PubMed] [Google Scholar]
- Fujimoto S., Matsuzawa T., Nakagawa K., Tada T. Cellular interaction between cytotoxic and suppressor T cells against syngeneic tumors in the mouse. Cell Immunol. 1978 Jul;38(2):378–387. doi: 10.1016/0008-8749(78)90068-0. [DOI] [PubMed] [Google Scholar]
- Hewitt H. B., Blake E. R., Walder A. S. A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin. Br J Cancer. 1976 Mar;33(3):241–259. doi: 10.1038/bjc.1976.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KALISS N. Immunological enhancement of tumor homografts in mice: a review. Cancer Res. 1958 Oct;18(9):992–1003. [PubMed] [Google Scholar]
- Klein G., Klein E. Rejectability of virus-induced tumors and nonrejectability of spontaneous tumors: a lesson in contrasts. Transplant Proc. 1977 Mar;9(1):1095–1104. [PubMed] [Google Scholar]
- Kärre K., Klein G. O., Kiessling R., Klein G., Roder J. C. Low natural in vivo resistance to syngeneic leukaemias in natural killer-deficient mice. Nature. 1980 Apr 17;284(5757):624–626. doi: 10.1038/284624a0. [DOI] [PubMed] [Google Scholar]
- McCoy J. L., Dean J. H., Law L. W., Williams J., McCoy N. T., Holiman B. J. Immunogenicity, antigenicity and mechanisms of tumor rejection of mineral-oil-induced plasmacytomas in syngeneic BALB/c mice. Int J Cancer. 1974 Aug 15;14(2):264–276. doi: 10.1002/ijc.2910140216. [DOI] [PubMed] [Google Scholar]
- Mengersen R., Schick R., Kölsch E. Correlation of "sneaking through" of tumor cells with specific immunological impairment of the host. Eur J Immunol. 1975 Aug;5(8):532–537. doi: 10.1002/eji.1830050805. [DOI] [PubMed] [Google Scholar]
- Naor D. Suppressor cells: permitters and promoters of malignancy? Adv Cancer Res. 1979;29:45–125. doi: 10.1016/s0065-230x(08)60846-5. [DOI] [PubMed] [Google Scholar]
- Perry L. L., Kripke M. L., Benacerraf B., Dorf M. E., Greene M. I. Regulation of the immune response to tumor antigen. VIII. The effects of host specific anti-I-J antibodies on the immune response to tumors of different origin. Cell Immunol. 1980 May;51(2):349–359. doi: 10.1016/0008-8749(80)90266-x. [DOI] [PubMed] [Google Scholar]
- Potter M., Walters J. L. Effect of intraperitoneal pristane on established immunity to the adj-PC-5 plasmacytoma. J Natl Cancer Inst. 1973 Sep;51(3):875–881. doi: 10.1093/jnci/51.3.875. [DOI] [PubMed] [Google Scholar]
- Röllinghoff M., Rouse B. T., Warner N. L. Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors. J Natl Cancer Inst. 1973 Jan;50(1):159–172. doi: 10.1093/jnci/50.1.159. [DOI] [PubMed] [Google Scholar]
- Sjögren H. O., Hellström I., Bansal S. C., Hellström K. E. Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes. Proc Natl Acad Sci U S A. 1971 Jun;68(6):1372–1375. doi: 10.1073/pnas.68.6.1372. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spellman C. W., Daynes R. A. Properties of ultraviolet light-induced suppressor lymphocytes within a syngeneic tumor system. Cell Immunol. 1978 Mar 15;36(2):383–387. doi: 10.1016/0008-8749(78)90282-4. [DOI] [PubMed] [Google Scholar]
- Takei F., Levy J. G., Kilburn D. G. Characterization of suppressor cells in mice bearing syngeneic mastocytoma. J Immunol. 1977 Feb;118(2):412–417. [PubMed] [Google Scholar]
- Talmadge J. E., Meyers K. M., Prieur D. J., Starkey J. R. Role of NK cells in tumour growth and metastasis in beige mice. Nature. 1980 Apr 17;284(5757):622–624. doi: 10.1038/284622a0. [DOI] [PubMed] [Google Scholar]
- Tilkin A. F., Schaaf-Lafontaine N., Van Acker A., Boccadoro M., Urbain J. Reduced tumor growth after low-dose irradiation or immunization against blastic suppressor T cells. Proc Natl Acad Sci U S A. 1981 Mar;78(3):1809–1812. doi: 10.1073/pnas.78.3.1809. [DOI] [PMC free article] [PubMed] [Google Scholar]